Superseded. This filing was amended. The current version is 0002048497-26-000016. This page remains published as the record of what was originally filed.
Sale of 36,870 shares at $18.4628 per share.
Reporting Person Hopman Mark · Officer Title Chief Commercial Officer · Transaction Code S
Traded Sep 9, 2026 · Disclosed Sep 10, 2026
Source: SEC Form 4 · 0002048497-26-000013 · filed 2026-09-10 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Beta Bionics, Inc. (BBNX)." Disclosed 2026-09-10. https://desqlong.com/cards/0002048497-26-000013-1 (retrieved 2026-09-26).